Charlas
1. Modelling the Cardiometabolic Diseases Burden Attributable to Ultra-Processed Foods in the Americas: The Case of Brazil and Canada
Eduardo Nilson; Center for Epidemiological Research in Nutrition and Public Health, University of São Paulo; Oswaldo Cruz Foundation-Fiocruz; Facultad de Ciencias de la Salud, Universidad Autónoma de Chile
Cardiovascular diseases are the leading cause of death globally and the prevalence of type 2 diabetes has increased sharply in the last 30 years. Cardiometabolic diseases rising prevalence parallel major shifts in dietary patterns marked by an overreliance on ultra-processed foods (UPF). Using a comparative risk-assessment model, we estimated how much of the burden of cardiovascular diseases and type 2 diabetes is attributable to UPF consumption among Canadian and Brazilian adults. We found that a substantial share of cardiometabolic diseases incidence, premature mortality, and disability-adjusted life years is linked to excessive UPF intake. Targeting UPF intake could protect cardiometabolic health.
2. Modelling the Cardiometabolic Diseases Burden Attributable to Ultra-Processed Foods in the Americas: The Case of Brazil and Canada
Leandro Rezende; Chronic Disease Epidemiology Research Center, Department of Preventive Medicine, Universidade Federal de São Paulo; Faculty of Health Sciences, Universidad Autónoma de Chile
Charla #1 will be co-presented by Dr Eduardo Nilson and Dr Leandro Rezende
3. Reducing Ultra-Processed Foods Consumption with Clinical Interventions: A Promising Pathway to Cardiometabolic Diseases Remission
Josep Iglesies-Grau; Research Center and Centre ÉPIC, Montreal Heart Institute; Department of Medicine and Department of Nutrition, Faculty of Medicine, University of Montreal
Ultra-processed foods (UPF) contribute to the global rise of cardiometabolic diseases. Multiple mechanisms link UPF to cardiometabolic diseases, many remain under investigation. Although chronic diseases like type 2 diabetes are typically viewed as incurable, evidence from Canada and elsewhere shows that reversal is possible through lifestyle interventions. At the Montreal Heart Institute, we conducted two pilot lifestyle-based remission trials, DIABEPIC-1 and -2. They combined UPF reduction alongside a Mediterranean diet, time-restricted eating, and supervised exercise. Remission occurred in 50% of participants with prediabetes and 38% with type 2 diabetes, suggesting that UPF reduction holds promise as a therapeutic pathway.
4. The Use of Screeners to Monitor Ultra-Processed Foods in Clinical Trials
Sara Desmarais; Research Center and Centre ÉPIC, Montreal Heart Institute; Department of Nutrition, Faculty of Medicine, University of Montreal; Centre de Recherche en Santé Publique
Ultra-processed foods and drinks (UPF) account for ~45% of Canadians’ daily caloric intake. The Canadian Ultra-Processed Food Screener (CUPS) was developed to assess rapidly UPF intake. The CUPS is used for the first time to monitor UPF consumption in a randomized controlled trial, DIABEPIC-REFORM. This study is the first randomized trial evaluating the added benefits of a UPF-reduction intervention integrated into a cardiac rehabilitation program. To date, no structured trial has tested whether individuals can be effectively taught to identify UPF, understand its health effects, and sustainably replace it in their diets to promote remission of cardiometabolic risk factors.
Financiamiento. Research relating to these abstracts was funded by The Montreal Heart Institute Foundation (Canada), The Heart and Stroke Foundation (Canada) and the Coordination of Superior Level Staff Improvement (CAPES, Brazil).
Conflicto de interés. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.